These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1100 related articles for article (PubMed ID: 12862255)
1. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years. Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of MDT in multibacillary leprosy. Jesudasan K; Vijayakumaran P; Manimozhi N; Rao PS; Samuel P Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):128-32. PubMed ID: 8690970 [TBL] [Abstract][Full Text] [Related]
4. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
5. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases. Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089 [TBL] [Abstract][Full Text] [Related]
6. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years. Norman G; Joseph G; Richard J Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321 [TBL] [Abstract][Full Text] [Related]
7. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences]. Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613 [TBL] [Abstract][Full Text] [Related]
8. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938 [TBL] [Abstract][Full Text] [Related]
9. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year. Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559 [TBL] [Abstract][Full Text] [Related]
11. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633 [TBL] [Abstract][Full Text] [Related]
12. Impact of multidrug therapy on leprosy in Baroda district (Gujarat). Chopra NK; Agarwal JS; Pandya PG Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026 [TBL] [Abstract][Full Text] [Related]
13. Fixed-duration therapy (FDT) in multibacillary leprosy; efficacy and complications. Vijayakumaran P; Jesudasan K; Manimozhi N Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):123-7. PubMed ID: 8690969 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
15. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy. Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy. Balagon MF; Cellona RV; Abalos RM; Gelber RH; Saunderson PR Lepr Rev; 2010 Mar; 81(1):27-33. PubMed ID: 20496567 [TBL] [Abstract][Full Text] [Related]
17. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens. Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893 [TBL] [Abstract][Full Text] [Related]
18. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil. Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two multidrug regimens in multibacillary leprosy. Jadhav VH; Patki AH; Mehta JM Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526 [TBL] [Abstract][Full Text] [Related]
20. Three years assessment of multidrug therapy in multibacillary leprosy cases. Ganapati R; Revankar CR; Pai RR Indian J Lepr; 1987; 59(1):44-9. PubMed ID: 3611860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]